Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research

Indian Heart J. 2022 Sep-Oct;74(5):341-350. doi: 10.1016/j.ihj.2022.07.009. Epub 2022 Aug 5.

Abstract

Cardiovascular Diseases (CVD) have a high disease burden in India. Dyslipidemia, a major CVD risk factor, requires effective management. Our review describes the appropriateness of the international dyslipidemia guidelines in the Indian context. A systematic search was performed in PubMed, Google Scholar, Cochrane Library and Science Direct to obtain relevant articles. Dyslipidemia management guidelines by western medical associations are based on their studies, with ethnic minorities underrepresented and biological features of other racial groups inadequately incorporated. The Lipid Association of India (LAI) came up with a consensus statement guided by an expert panel to adapt the western guidelines to Indians. However, absence of Indian guidelines has led to physicians basing treatment on individual preference, contributing to heterogeneity. Our review underscores the need for formulating Indian dyslipidemia management guidelines and CV risk estimation algorithms, highlighting the scope for further research. This could supplement the clinical expertise of LAI and enhance patient experience.

Keywords: Cardiovascular disease; Dyslipidemia; Dyslipidemia management; India; Lipids.

Publication types

  • Review

MeSH terms

  • Asian People
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / prevention & control
  • Consensus
  • Dyslipidemias* / drug therapy
  • Dyslipidemias* / epidemiology
  • Humans
  • India / epidemiology
  • Racial Groups